G. Martorana

496 total citations
19 papers, 333 citations indexed

About

G. Martorana is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G. Martorana has authored 19 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G. Martorana's work include Hormonal and reproductive studies (4 papers), Renal cell carcinoma treatment (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). G. Martorana is often cited by papers focused on Hormonal and reproductive studies (4 papers), Renal cell carcinoma treatment (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). G. Martorana collaborates with scholars based in Italy, Switzerland and United Kingdom. G. Martorana's co-authors include Gennaro Scarselli, F Branconi, E. del Pozo, Ioana Lancranjan, Mario Bigazzi, Claudio Giberti, Kirsten M. Vogelsong, William J. Bremner, Silvia Cerpolini and Maria Cristina Meriggiola and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Human Reproduction.

In The Last Decade

G. Martorana

18 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Martorana Italy 9 118 75 73 73 71 19 333
Fred K. Kirchner United States 9 108 0.9× 161 2.1× 196 2.7× 62 0.8× 78 1.1× 25 518
Süleyman Engin Akhan Türkiye 11 41 0.3× 109 1.5× 63 0.9× 57 0.8× 66 0.9× 35 367
Irwin J. Kerber United States 8 122 1.0× 100 1.3× 43 0.6× 14 0.2× 65 0.9× 12 406
Yagil Barazani United States 8 25 0.2× 97 1.3× 64 0.9× 32 0.4× 46 0.6× 19 305
Milagros Alonso Spain 12 179 1.5× 97 1.3× 85 1.2× 80 1.1× 131 1.8× 23 473
H Klosterhalfen Germany 9 76 0.6× 25 0.3× 56 0.8× 119 1.6× 12 0.2× 58 263
I. Qvist Denmark 9 59 0.5× 158 2.1× 43 0.6× 35 0.5× 113 1.6× 13 519
Katherine D. Henderson United States 11 147 1.2× 151 2.0× 69 0.9× 28 0.4× 85 1.2× 12 602
Romain Boissier France 7 33 0.3× 110 1.5× 70 1.0× 41 0.6× 67 0.9× 18 294
Jean‐Marie Limal France 12 256 2.2× 34 0.5× 82 1.1× 45 0.6× 18 0.3× 16 524

Countries citing papers authored by G. Martorana

Since Specialization
Citations

This map shows the geographic impact of G. Martorana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Martorana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Martorana more than expected).

Fields of papers citing papers by G. Martorana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Martorana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Martorana. The network helps show where G. Martorana may publish in the future.

Co-authorship network of co-authors of G. Martorana

This figure shows the co-authorship network connecting the top 25 collaborators of G. Martorana. A scholar is included among the top collaborators of G. Martorana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Martorana. G. Martorana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vagnoni, Valerio, et al.. (2011). 562 THE EXTENT OF PELVIC LYMPH NODE DISSECTION CORRELATES WITH THE BIOCHEMICAL RECURRENCE RATE IN PATIENTS WITH INTERMEDIATE- AND HIGH- RISK PROSTATE CANCER. European Urology Supplements. 10(2). 185–185. 3 indexed citations
2.
Meriggiola, Maria Cristina, Silvia Cerpolini, William J. Bremner, et al.. (2006). Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. Human Reproduction. 21(8). 2033–2040. 48 indexed citations
3.
Pozzo, L. Da, B. Mazzoccoli, P. Rigatti, et al.. (2006). TISSUE RESONANCE INTERACTION METHOD (TRIMPROB™) FOR NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER:A MULTICENTRE CLINICAL EVALUATION. European Urology Supplements. 5(2). 209–209. 1 indexed citations
4.
Iacopino, Fortunata, Cristiana Angelucci, Giovanni Zelano, et al.. (2006). Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.. PubMed. 26(3A). 1849–54. 20 indexed citations
5.
Emberton, Mark & G. Martorana. (2006). BPH: Social Impact and Patient's Perspective. European Urology Supplements. 5(20). 991–996. 9 indexed citations
6.
Mancini, Antonio, Elisabetta Meucci, Domenico Milardi, et al.. (2004). Seminal Antioxidant Capacity in Pre‐ and Postoperative Varicocele. Journal of Andrology. 25(1). 44–49. 41 indexed citations
7.
Bertaccini, A., et al.. (1999). Biopsying prostate gland: telomerase evaluation. Prostate Cancer and Prostatic Diseases. 2(S3). S6–S6. 1 indexed citations
8.
Pezzilli, Raffaele, et al.. (1999). Serum prostate-specific antigen in pancreatic disease.. PubMed. 31(7). 580–3. 4 indexed citations
9.
Martorana, G., et al.. (1997). Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia.. PubMed. 32(1). 47–53. 38 indexed citations
10.
Boccardo, Francesco, A. Rubagotti, Domenico Guarneri, et al.. (1994). Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.. Journal of Clinical Oncology. 12(1). 7–13. 38 indexed citations
11.
Giuliani, L., et al.. (1988). Lymphadenectomy during radical cystectomy for bladder cancer.. PubMed. 260. 329–39.
12.
Boccardo, Francesco, Andrea DeCensi, Domenico Guarneri, et al.. (1987). Long‐term results with a long‐acting formulation of D‐TRP‐6 LH‐RH in patients with prostate cancer: An Italian prostatic cancer project (P.O.N.CA.P.) study. The Prostate. 11(3). 243–255. 14 indexed citations
13.
Giuliani, Luciano, Claudio Giberti, G. Martorana, & Salvatore Rovida. (1986). Surgical Management of Renal Cell Carcinoma with Vena CavaTumor Thrombus. European Urology. 12(3). 145–150. 10 indexed citations
14.
Martorana, G., et al.. (1982). Il Ruolo Della Fenossibenzamina Nel Trattamento Dell'Adenoma Della Prostata. Urologia Journal. 49(2). 229–232. 2 indexed citations
15.
Leone, Giuseppe, et al.. (1982). [Gaucher's disease: hemorrhagic diathesis and term pregnancy with the birth of a malformed fetus].. PubMed. 73(27). 1899–902. 1 indexed citations
16.
Giuliani, L., et al.. (1981). [Surgical treatment of renal adenocarcinoma with neoplastic thrombosis of the inferior vena cava].. PubMed. 36(6). 401–8. 2 indexed citations
17.
Giuliani, L., et al.. (1980). [Renal adenocarcinoma with neoplastic thrombus in the inferior vena cava. Prognosis and operative risk].. PubMed. 35(4). 287–92. 1 indexed citations
18.
Martorana, G., Claudio Giberti, & G. Carmignani. (1979). Renal venous samples during active renin secretion in the prognosis of surgery for renovascular hypertension. 9(2). 184–190. 1 indexed citations
19.
Bigazzi, Mario, Ioana Lancranjan, F Branconi, et al.. (1979). A Pregnancy in an Acromegalic Woman during Bromocriptine Treatment: Effects on Growth Hormone and Prolactin in the Maternal, Fetal, and Amniotic Compartments*. The Journal of Clinical Endocrinology & Metabolism. 48(1). 9–12. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026